argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
740.40
+22.60 (3.15%)
At close: Mar 9, 2026, 4:00 PM EDT
740.73
+0.33 (0.04%)
After-hours: Mar 9, 2026, 6:35 PM EDT
argenx SE Employees
argenx SE had 1,599 employees as of December 31, 2024. The number of employees increased by 451 or 39.29% compared to the previous year.
Employees
1,599
Change (1Y)
451
Growth (1Y)
39.29%
Revenue / Employee
$2,656,692
Profits / Employee
$808,027
Market Cap
44.74B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 1,599 | 451 | 39.29% |
| Dec 31, 2023 | 1,148 | 305 | 36.18% |
| Dec 31, 2022 | 843 | 193 | 29.69% |
| Dec 31, 2021 | 650 | 314 | 93.45% |
| Dec 31, 2020 | 336 | 148 | 78.72% |
| Dec 31, 2019 | 188 | 83 | 79.05% |
| Dec 31, 2018 | 105 | 32 | 43.84% |
| Dec 31, 2017 | 73 | 15 | 25.86% |
| Dec 31, 2016 | 58 | 17 | 41.46% |
| Dec 31, 2015 | 41 | 9 | 28.13% |
| Dec 31, 2014 | 32 | 10 | 45.45% |
| Dec 31, 2013 | 22 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Regeneron Pharmaceuticals | 15,410 |
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 6,772 |
| Vertex Pharmaceuticals | 6,400 |
| Moderna | 4,700 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| Insmed | 1,664 |
ARGX News
- 16 hours ago - Wedbush Reiterates Outperform Rating for argenx (ARGX) with $1000 Price Target | ARGX Stock News - GuruFocus
- 4 days ago - argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline - GlobeNewsWire
- 4 days ago - Oversold Conditions For argenx (ARGX) - Nasdaq
- 5 days ago - Here's How Much $100 Invested In argenx 5 Years Ago Would Be Worth Today - Benzinga
- 6 days ago - Baron Health Care Fund Q4 2025 Contributors And Detractors - Seeking Alpha
- 7 days ago - argenx SE at TD Cowen Healthcare Conference Transcript - GuruFocus
- 10 days ago - RBC Capital Lowers Price Target for argenx (ARGX) Amidst Maintained 'Outperform' Rating | ARGX ... - GuruFocus
- 10 days ago - Wells Fargo Lowers Price Target for argenx (ARGX) but Maintains Overweight Rating | ARGX Stock News - GuruFocus